Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Nova Eye Medical Limited is a medical devices business based in Australia. Ellex Medical Lasers shares (ELX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Ellex Medical Lasers has a trailing 12-month revenue of around $12.8 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Ellex Medical Lasers
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Ellex Medical Lasers . Find the share by name or ticker symbol: ELX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Ellex Medical Lasers reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Ellex Medical Lasers . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
ETF investing
Our top pick for
Overall broker
What's in this guide?
- Ellex Medical Lasers key stats
- Compare share trading platforms
- Is Ellex Medical Lasers stock a buy or sell?
- Ellex Medical Lasers performance over time
- Are Ellex Medical Lasers shares over-valued?
- Ellex Medical Lasers 's financials
- How volatile are Ellex Medical Lasers shares?
- Does Ellex Medical Lasers pay a dividend?
- Have Ellex Medical Lasers shares ever split?
- Other common questions
Ellex Medical Lasers stock price (ASX:ELX)
Use our graph to track the performance of ELX stocks over time.Ellex Medical Lasers shares at a glance
Information last updated 2021-01-28.
| 52-week range | $0.315 - $0.365 |
|---|---|
| 50-day moving average | $0.3422 |
| 200-day moving average | $0.3459 |
| Target price | $1.69 |
| PE ratio | 2.8629 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.248 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Ellex Medical Lasers stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Ellex Medical Lasers under- or over-valued?
Valuing Ellex Medical Lasers stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ellex Medical Lasers 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ellex Medical Lasers 's P/E ratio
Ellex Medical Lasers 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Ellex Medical Lasers shares trade at around 3x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ellex Medical Lasers 's EBITDA
Ellex Medical Lasers 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $679,000 (£370,211).
The EBITDA is a measure of a Ellex Medical Lasers 's overall financial performance and is widely used to measure a its profitability.
Ellex Medical Lasers financials
| Revenue TTM | $12.8 million |
|---|---|
| Gross profit TTM | $9.7 million |
| Return on assets TTM | -4.14% |
| Return on equity TTM | 0% |
| Profit margin | 279.22% |
| Book value | 0.7 |
| Market capitalisation | $102 million |
TTM: trailing 12 months
Ellex Medical Lasers share dividends
We're not expecting Ellex Medical Lasers to pay a dividend over the next 12 months.
Have Ellex Medical Lasers 's shares ever split?
Ellex Medical Lasers 's shares were split on a 1:5 basis on 9 July 2001. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ellex Medical Lasers shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Ellex Medical Lasers shares which in turn could have impacted Ellex Medical Lasers 's share price.
Ellex Medical Lasers share price volatility
Over the last 12 months, Ellex Medical Lasers 's shares have ranged in value from as little as $0.315 up to $0.365. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Ellex Medical Lasers 's is 0.6182. This would suggest that Ellex Medical Lasers 's shares are less volatile than average (for this exchange).
Ellex Medical Lasers overview
Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Ellex Medical Lasers in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy BITO ETF units | $39.51
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
-
Why is the AMP share price looking up today?
Shares in the wealth management giant have been largely stable in the last 6 months.
-
How to invest in the Judo Capital Holdings IPO
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
-
How to invest in the Alloggio Group IPO
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
-
How to invest in the Larvotto Resources IPO
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
-
How to invest in the Vulcan Steel IPO
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
-
How to invest in the Artrya IPO
Everything we know about the Artrya IPO, plus information on how to buy in.
-
How to invest in the 8 Au IPO
Everything we know about the 8 Au IPO, plus information on how to buy in.
-
How to invest in the Radiopharm Theranostics IPO
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
-
What has prompted the rebound in the Kogan share price?
The online retailer’s shares have lost more than half their value in the last 12 months.
Ask an Expert
